Tilray Brands (TLRY) Total Liabilities (2017 - 2026)
Tilray Brands (TLRY) posted Total Liabilities of $549.1 million for Q1 2026, down 0.54% on a QoQ basis from $552.1 million in Q4 2025.
Tilray Brands (TLRY) Total Liabilities (2017 - 2026) Analysis & Trends
Tilray Brands' Total Liabilities history runs 10 years deep, the most recent figure standing at $549.1 million for Q1 2026.
- Quarterly Total Liabilities changed N/A year-over-year to $549.1 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $549.1 million (changed N/A YoY) and the FY2025 annual result came in at $584.8 million, down 24.89% from the prior year.
- Total Liabilities was $549.1 million for Q1 2026 at Tilray Brands, down from $552.1 million in the prior quarter.
- Across five years, Total Liabilities topped out at $1.2 billion in Q1 2022 and bottomed at $549.1 million in Q1 2026.
- A 5-year average of $842.8 million and a median of $903.5 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities slumped 35.69% — and 2023, when it fell 2.78%.
- Tilray Brands' Total Liabilities stood at $991.2 million in 2022, then dropped by 5.45% to $937.2 million in 2023, then fell by 21.24% to $738.1 million in 2024, then declined by 25.21% to $552.1 million in 2025, then declined by 0.54% to $549.1 million in 2026.
- Business Quant data shows TLRY's Total Liabilities at $549.1 million in Q1 2026, $552.1 million in Q4 2025, and $562.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 549.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 549.12 Mn |
| Nov 30, 2025 | 552.09 Mn |
| Aug 31, 2025 | 561.99 Mn |
| May 31, 2025 | 584.75 Mn |
| Nov 30, 2024 | 738.15 Mn |
| Aug 31, 2024 | 778.45 Mn |
| May 31, 2024 | 778.49 Mn |
| Feb 29, 2024 | 869.82 Mn |
| Nov 30, 2023 | 937.20 Mn |
| Aug 31, 2023 | 1.00 Bn |
| May 31, 2023 | 977.32 Mn |
| Feb 28, 2023 | 969.13 Mn |
| Nov 30, 2022 | 991.23 Mn |
| Aug 31, 2022 | 1.03 Bn |
| May 31, 2022 | 1.01 Bn |
| Feb 28, 2022 | 1.16 Bn |
| Nov 30, 2021 | 1.29 Bn |
| Aug 31, 2021 | 1.60 Bn |
| May 31, 2021 | 1.56 Bn |
| May 31, 2020 | 463.00 Mn |